| Dr Clifford Michael Sonnie, MD, MPH | |
|
3985 Medina Rd, Suite 250, Medina, OH 44256-5968 | |
| (330) 764-4242 | |
| Not Available |
| Full Name | Dr Clifford Michael Sonnie |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 3985 Medina Rd, Medina, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598865123 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 049066 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Clifford Michael Sonnie, MD, MPH 3985 Medina Rd, Suite 250, Medina, OH 44256-5968 Ph: (330) 764-4242 | Dr Clifford Michael Sonnie, MD, MPH 3985 Medina Rd, Suite 250, Medina, OH 44256-5968 Ph: (330) 764-4242 |
News Archive
"China could be considering relaxing its ... one-child policy," which "is increasingly being seen as an impediment to growth and the harbinger of social problems," such as a declining workforce, Reuters reports.
Kidneys from deceased donors with hepatitis C virus (HCV) infection can be safely transplanted into noninfected recipients when a regimen of direct-acting antiviral therapies is initiated as early as two days after the transplant, according to a study from Massachusetts General Hospital (MGH).
Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.
Phage therapy may be a solution to treating infections caused by antibiotic-resistant bacteria. Since 2013, researchers at the University of Helsinki in Finland have collected bacteriophages to combat antibiotic-resistant bacterial strains, and hope to start clinical phage therapy trials in the near future.
Researchers from the Oxford University Department of Human Anatomy and Genetics have found a new class of genes that are critical for cell growth and may be involved in the uncontrolled growth that takes place in cancer. The discovery could provide a key to future tumour therapies.
› Verified 4 days ago
Kirby J Flanagan, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 3920 Burgundy Bay Blvd W, Medina, OH 44256 Phone: 330-903-2578 Fax: 330-241-5555 | |
Lisa Anne Klatka, D.O. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 4800 Ledgewood Dr, Medina, OH 44256 Phone: 330-723-9688 Fax: 330-723-9697 | |
Dr. Douglas Weeks, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 3985 Medina Rd, Suite 250, Medina, OH 44256 Phone: 330-764-4242 |